Program Purpose
Specifically designed by the Society for Immunotherapy of Cancer (SITC), the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CNE- and CPE-certified programs, presented by leading, local authorities in tumor immunology and cancer immunotherapy.
These six-hour in-person programs will facilitate understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments; strategies for overcoming operational and reimbursement barriers to implementing immunotherapy in a community setting; and the identification and management of immune-related adverse events.
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the in-person event, through two Immuno-Oncology (I-O) Cup o' Joe webinars after the program, and indefinitely through a dedicated online CONNECT community forum, which will serve as ongoing resources.
New this year, SITC is partnering with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC) to provide guidance for emergency physicians in identifying and managing patients who present to the ER with immune-related adverse events, and practical information about the necessary hospital operations for providing immunotherapy and strategies for obtaining reimbursement.